Install
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
- 3,491articles · 365d
- 12+ hour agolatest article
- Sep 15, 2025earliest in window
- 95%with images
- 272avg words
- Medical 2,391
- Health & Wellness 2,275
- Health 1,662
- Business & Industrial 819
- Science & Technology 643
- Economy, Business & Finance 533
- Politics2 393
- Politics 367
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
The gifts from pharma companies that keep on giving
3+ day, 18+ hour ago (218+ words) Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for more than three decades. His stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation and legislation. He is…...
Public-sector purgatory, and a union-hospital fight
2+ week, 6+ day ago (201+ words) Bob Herman covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He was named a Pulitzer co-finalist in 2024 for the series…...
More workers hate their jobs, but keep them for the health insurance
1+ mon, 3+ week ago (210+ words) Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine. An increasing number of adults are slogging through jobs they don’t like solely because they don’t want to lose their…...
Despite earnings celebration, UnitedHealth signals more financial pain for employers
1+ mon, 4+ week ago (220+ words) Bob Herman is the author of Health Care Inc., an award-winning weekly newsletter about the business of health and medicine. UnitedHealth Group smashed through investors’ earnings expectations in the second quarter, with executives confidently saying this new level of profit…...
Affordable Care Act insurers want more premium increases as enrollment sags
2+ mon, 5+ day ago (691+ words) By Rachel Spears — KFF Health News For the second year in a row, many Affordable Care Act insurers are proposing double-digit premium increases, driven by rising medical costs as well as policy changes by Congress and the Trump administration. In…...
5 takeaways from STAT’s series on the soaring cost of health insurance
2+ mon, 1+ week ago (207+ words) More than 150 million Americans get their health insurance from a job, making it the primary way people in the U.S. get coverage. STAT is examining this crucial source of insurance to understand how and why it is becoming unaffordable for workers…...
A suspicious denial pattern in Medicare Advantage
3+ mon, 2+ day ago (122+ words) statnews.com For those interested in peptides, stem cells, supplements, red light treatments, hyperbaric chambers, body vibration devices, or getting ion balances through walking barefoot — RFK Jr.’s most recent podcast might be worth a listen. Send news tips and…...
The medical-billing AI arms race between providers and insurance
3+ mon, 1+ week ago (1126+ words) In November 2020, Bisi Bennett went into labor at seven months pregnant. Halfway to AdventHealth hospital, with her husband, Chris, behind the wheel, she gave birth to their son Dorian in their Mitsubishi Outlander. He didn’t breathe. At the hospital, before…...
Maryland state affordability board places a price cap on Ozempic
3+ mon, 3+ week ago (268+ words) Ed Silverman is a senior writer and Pharmalot columnist at STAT, and has covered the pharmaceutical industry for three decades. Prior to joining STAT at its founding in 2015, he worked at The Wall Street Journal, The Star-Ledger of New Jersey,…...
Pharma companies and patient groups seek to exempt orphan drugs from Colorado pricing limits
5+ mon, 1+ week ago (452+ words) Ed Silverman is a senior writer and Pharmalot columnist at STAT, and has covered the pharmaceutical industry for three decades. Prior to joining STAT at its founding in 2015, he worked at The Wall Street Journal, The Star-Ledger of New Jersey,…...